CD40 ligation induces apo-1/fas expression on human B lymphocytes and facilitates apoptosis through the apo-1/fas pathway

Journal of Experimental Medicine

Volumn 182, Issue 5, 1995, Pages 1557-1565

  Schattner, Elaine J ^a   Elkon, Keith B ^a   Yoo, Dae Hyun ^a   Tumang, Joseph ^b   Krammer, Peter H ^c   Crow, Mary K ^a   Friedman, Steven M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; DNA; FAS ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; SUPERANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL INTERACTION; CELL MUTANT; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LIGATION; LYMPHOMA CELL LINE; PRIORITY JOURNAL; T LYMPHOCYTE; TONSIL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD40; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; BURKITT LYMPHOMA; CD40 LIGAND; CELLS, CULTURED; COMPARATIVE STUDY; DNA DAMAGE; DNA, NEOPLASM; GENE EXPRESSION REGULATION; HUMAN; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TONSIL; TUMOR CELLS, CULTURED;

EID: 0028865583     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.5.1557     Document Type: Article

References (43)

1. Oehm, A., I. Behrmann, W. Falk, M. Pawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B.C. Trauth et al. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol. Chem. 267: 10709-10715.
2. Watanabe-Fukunaga, R., C.I. Brannan, N.G. Copeland, N.A. Jenkins, and S. Nagata. 1993. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.). 356:314-317.
3. Drappa, J., N. Brot, and K.B. Elkon. 1993. The Fas protein is expressed at high levels on double-positive thymocytes and activated mature T cells in normal but not MRL/lpr mice. Proc. Natl. Acad. Sci. USA. 90:10340-10344.
4. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand. Cell. 76:969-976.
5. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P.H. Krammer. 1995. Autocrine T cell suicide mediated by APO-1 /(Fas/CD95). Nature (Lond.). 373:438-440.
6. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/ Fas ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.). 373:441-444.
7. Ju, S.-T., D.J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T cell activation. Nature (Lond.). 373:444-448.
8. Alderson, M.R., T.W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Ramsdell, and D.H. Lynch. 1995. Fas ligand mediates activationinduced cell death in human T lymphocytes. J. Exp. Med. 181:71-77.
9. Owen-Schaub, L.B., S. Yonehara, W.L. Crump III, andE.A. Grimm. 1992. DNA fragmentation and cell death are selectively triggered by activated human lymphocytes by Fas antigen engagement. Clin. Immunol. 140:197-205.
10. Daniel, P.T., and P.H. Krammer. 1994. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J. Immunol. 152:5624-5632.
11. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753-3758.
12. Ju, S.-T., H. Cui, D.J. Panka, R. Ettinger, and A. MarshakRothstein. 1994. Participation of target Fas protein in apoptosis pathway induced by CD4+ Thl and CD8+ cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 91:4185-4189.
13. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. 1994. Fas and its ligand in a general mechanism of T cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:4930-4934.
14. Dhein, J., P.T. Daniel, B.C. Trauth, A. Oehm, P. Moller, and P.H. Krammer. 1992. Induction of apoptosis by monoclonal antibody anti-Apo-1 class switch variants is dependent on cross-linking of Apo-1 cell surface antigens. J. Immunol. 149:3166-3173.
15. Trauth, B.C., C. Klas, A.M.J. Peters, S. Matzku, P. Moller, W. Falk, K.M. Debatin, and P.H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC). 245:301-305.
16. Liu, Y.-J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and I.C.M. MacLennan. 1989. Mechanism of antigen driven selection in germinal centers. Nature (Lond.). 342:929-931.
17. Lederman, S., M.J. Yellin, A. Krichevsky, J. Belko, J.J. Lee, and L. Chess. 1992. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091-1101.
18. Banchereau, J., F. Bazan, D. Blanchard, F. Briere, J.P. Galizzi, C. van Kooten, Y.J. Liu, F. Rousset, and S. Saeland. 1994. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12:881-922.
19. Berberich, I., G.L. Shu, and E.A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-«B. J. Immunol. 153:4357-4366.
20. Yellin, M.J., J. Sinning, L.R. Covey, W. Sherman, J.J. Lee, E. Glickman-Nir, K.C. Sippel, J. Rogers, A.M. Cleary, M. Parker et al. 1994. T lymphocyte T cell-B cell-activating molecule/CD40-L molecules induce normal B cells or chronic lymphocytic leukemia B cells to express CD80 (B7/ BB-1) and enhance their costimulatory activity. J. Immunol. 153:666-674.
21. Duriek, F.H., T.M. Foy, S.R. Masters, J.D. Laman, and R.J. Noele. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15:406-411.
22. Faris, M., F. Gaskin, J.T. Parsons, and S.M. Fu. 1994. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine phosphorylated proteins including protein tyrosine kinase lyn, fyn, and syk and the appearance of a 28-kD tyrosine-phos phorylated protein. J. Exp. Med. 179:1923-1931.
23. Lederman, S., M.J. Yellin, A.M. Cleary, A. Pemis, G. Inghirami, L.E. Cohn, L.R. Covey, J.J. Lee, P. Rothman, and L. Chess. 1994. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death. J. Immunol. 152:2163-2171.
24. Splawski, J.B., S.M. Fu, and P.E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276-1285.
25. Grabstein, K.H., C.R. Maliszewski, K. Shanebeck, T.A. Sato, M.K. Spriggs, W.C. Fanslow, and R.J. Armitage. 1993. The regulation of T cell-dependent antibody formation in vitro by CD40 ligand and IL-2. J. Immunol. 150:3141-3147.
26. Gregory, C.D., T. Tursz, C.F. Edwards, C. Tetaud, M. Talbot, B. Caillou, A.B. Rickinson, and M. Lipinski. 1987. Identification of a subset of normal B cells with a Burkitt’s lymphoma (BL)-like phenotype. J. Immunol. 139:313-318.
27. Falk, M.H., B.C. Trauth, K.-M. Debatin, C. Klas, C.D. Gregory, A.B. Rickinson, A. Calender, G.M. Lenoir, J.W. Ellwart, P.H. Krammer, and G.W. Bomkamm. 1992. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood. 79:3300-3306.
28. Tumang, J.R., D.N. Posnett, B.C. Cole, M.K. Crow, and S.M. Friedman. 1990. Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J. Exp. Med. 171:2153-2158.
29. Yellin, M.J., J.J. Lee, L. Chess, and S. Lederman. 1991. A human CD4" T cell leukemia subclone with contact-dependent helper function. J. Immunol. 147:3389-3395.
30. Atkin, C.L., S. Wei, and B.C. Cole. 1994. The Mycoplasma arthritidis superantigen MAM: purification and identification of an active peptide. Infect. Immun. 62:5367-5375.
31. Marrack, P., and J. Kappler. 1990. The staphylococcal enterotoxins and their relatives. Science (Wash. DC). 248:705-711.
32. Mollick, J.A., R.G. Cook, and R.R. Rich. 1989. Class II MHC molecules are specific receptors for Staphylococcus enterotoxin A. Science (Wash. DC). 244:817-820.
33. Friedman, S.M., J.R. Tumang, and M.K. Crow. 1993. Microbial superantigens as etiopathogenic agents in autoimmunity. Rheum. Dis. Clin. North Am. 19:207-222.
34. Bretscher, P., and M. Cohn. 1970. A theory of self-nonself discrimination. Science (Wash. DC). 169:1042-1049.
35. Julius, M.H., H. von Boehmer, and C.L. Sidman. 1982. Dissociation of two signals required for activation of resting B cells. Proc. Natl. Acad. Sci. USA. 79:1989-1994.
36. Mourad, W., P. Scholl, A. Diaz, R. Geha, and T. Chatila. 1989. The staphylococcal toxic shock syndrome toxin 1 triggers B cell proliferation and differentiation via major histocompatibility complex-unrestricted cognate T/B cell interaction. J. Exp. Med. 170:2011-2022.
37. Tumang, J.R., E.P. Cherniak, D.M. Gietl, B.C. Cole, C. Russo, M.K. Crow, and S.M. Friedman. 1991. T helper celldependent, microbial superantigen-induced murine B cell activation: polyclonal and antigen-specific antibody responses. J. Immunol. 147:432-438.
38. Held, W., A.N. Shakhou, S. Izui, G.A. Waanders, L. Scarpellino, H.R. MacDonald, and H. Acha-Orbea. 1993. Superantigen-reactive CD4+ T cells are required to stimulate B cells after infection with mouse mammary tumor virus. J. Exp. Med. 177:359-366.
39. Jover, J.A., E.K. Chartash, B. Kushner, S.M. Friedman, and M.K. Crow. 1989. T helper cell-induced CD23 (BLAST-2) expression: an activation marker for the high density fraction of human B cells. Clin. Immunol. Immunopathol. 53:99-112.
40. Mosmann, T.R., and R.L. Coffman. 1989. Thl and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
41. Aruffo, A, M. Farrington, D. Hollenbaugh, X. Li, A. Milatovich, S. Nonoyama, J. Bajorath, L.S. Grosmaire, R. Stenkamp, M. Neubauer et al. 1993. The CD40 Ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell. 72:291-300.
42. DiSanto, J.P., J.Y. Bonnefoy, J.F. Gauchat, A. Fischer, and G. De Saint Basile. 1993. CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature (Lond.). 361: 541-543.
43. Levine, A. 1992. Acquired immunodeficiency syndromerelated lymphoma. Blood. 80:8-20.